CLINICAL_TRIALS
trial_result
· 2010-10-11
Clinical Trial Update: The Effect of Sitagliptin in Type 2 Diabetes Mellitus With Inadequate Glycemic Control (MK0431-118) [Phase 4]
Summary
Phase 4 trial evaluating sitagliptin in adults with type 2 diabetes and inadequate glycemic control was terminated; results were posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus Non-insulin-dependent | Phase 4 | Status: TERMINATED | Results posted: 2010-10-11